Ranh Voong

Medicine & Life Sciences

1. Radiotherapy 100%
2. Non-Small Cell Lung Carcinoma 74%
3. Radiation 67%
4. Lung Neoplasms 63%
5. Neoplasms 36%
6. Pneumonia 32%
7. Radiosurgery 31%
8. Survival 29%
9. Immunotherapy 29%
10. Neoplasm Metastasis 27%
11. Therapeutics 26%
12. Microtubules 24%
13. Pancreatic Carcinoma 20%
14. Thorax 19%
15. Lung 18%
16. Adenosquamous Carcinoma 17%
17. Drug Therapy 17%
18. Paclitaxel 17%
19. M Phase Cell Cycle Checkpoints 17%
20. Weight Loss 16%
21. Progression-Free Survival 16%
22. Peer Review 15%
23. AZD3409 14%
24. Prostate 13%
25. Prostatic Neoplasms 13%
26. Recurrence 13%
27. Brain 13%
28. Esophageal Neoplasms 13%
29. Patient Reported Outcome Measures 12%
30. Tumor Burden 11%
31. Ruthenium-106 11%
32. Dimethylallyltranstransferase 11%
33. Sp Transcription Factors 11%
34. durvalumab 11%
35. Esophagus 10%
36. Radiation-Sensitizing Agents 10%
37. Health Expenditures 10%
38. Cranial Irradiation 10%
39. Physicians 10%
40. Thymic epithelial tumor 10%
41. Pancreatic Neoplasms 9%
42. Radiation Oncology 9%
43. Nocodazole 9%
44. Esophagitis 9%
45. Machine Learning 9%
46. Butterflies 9%
47. Iodine-125 8%
48. Incidence 8%
49. Deep Learning 8%
50. Big Data 8%